KT Medical Service Public Company Limited

KT Medical Service Public Company Limited

1.33
THB
+0.02
(+1.53%)
0.12EPS
10.72P/E
387.00MMarket Cap
KT Medical Service Public Company Limited
SET:KTMS.R
(Stock Exchange of Thailand)

Recent

price

1.33

P/E

ratio

10.72

div

yld

0.98%

ROIC.AI

2020
2021
2022
2023
2024
2025
TTM
THB
0.71
1.03
1.67
1.52
1.99
2.35
2.37
Revenue per Share
-0.08
0.06
0.09
0.05
0.06
0.15
0.12
Basic EPS, GAAP
-0.04
-0.14
-0.2
-0.48
-0.01
-0.08
-0.02
Free Cash Flow per Basic Share
- -
- -
- -
0.03
0.01
0.02
0.01
Dividend per Share
0.12
0.78
1.62
1.63
1.68
1.8
1.83
Book Value per Share
0.12
0.77
1.62
1.63
1.67
1.8
1.82
Tangible Book Value per Share
300
300
227
300
300
300
300
Basic Weighted Avg Shares
212
309
378
456
597
704
712
Sales/Revenue/Turnover
-9.98
8.25
7.59
4.43
4.45
8.65
7.32
Operating Margin (%)
18
21
22
27
40
46
48
Depreciation Expense
-24
17
21
14
19
44
36
Net Income, GAAP
- -
19.29
19.03
26.33
24.11
21.55
22.76
Effective Tax Rate (%)
-11.49
5.43
5.61
3.12
3.21
6.3
5.07
Profit Margin (%)
-58
130
350
209
172
233
218
Working Capital
42
46
68
32
23
36
29
LT Debt
36
233
487
494
506
543
552
Total Equity
- -
9.54
5.82
2.89
3.91
8.39
6.83
Return on Invested Capital (%)
- -
9.08
5.57
3.01
4.04
8.24
6.79
Return on Capital (%)
- -
12.51
5.9
2.91
3.86
8.51
6.78
Return on Common Equity (%)

Capital Structure

THB

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
48
48
49
LT Borrowings
25
20
19
LT Finance Leases
12
11
10
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
300
300
300
Market Capitalization
594
426
387

Working Capital

THB

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
445
451
459
Cash, Cash Equivalents & STI
93
78
87
Accounts Receivable, Net
205
242
232
Inventories
36
33
38
Total Current Liabilities
212
214
242
Payables & Accruals
133
132
161
ST Debt
48
48
49
Deferred Revenue
- -
- -
- -

Growth Rates

THB

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
133.65%
7.33%
Free Cash Flow
- -
178.64%
490.55%
Net Income, GAAP
- -
-1.93%
131.5%
Sales/Revenue/Turnover
- -
27.58%
17.94%
Total Cash Common Dividend
- -
- -
66.39%

Quarterly Revenue

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
126
149
158
164
597
2025
169
173
180
181
704
2026
174
176
- -
- -
- -

Quarterly Earnings Per Share

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
0.02
0.01
0.02
0.06
2025
0.04
0.03
0.04
0.04
0.15
2026
0.02
0.02
- -
- -
- -

Quarterly Dividends Per Share

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.01
- -
- -
0.01
2025
- -
0.02
- -
- -
0.02
2026
- -
0.01
- -
- -
- -
Business
Kt Medical Service Public Company Limited operates hemodialysis centers and provides related medical services in Thailand. Founded in 2015 and headquartered in Bangkok, the company offers hemodialysis services through two models: outsourced units in public hospitals serving patients under national health security schemes including the National Health Security Office, civil servant medical welfare, local administrative organizations, social security, and cash payments; and stand-alone dialysis clinics for public health scheme patients and cash-paying individuals, adhering to Ministry of Public Health standards and the Nephrology Society of Thailand guidelines. It also designs, assembles, installs, and maintains water purification systems using reverse osmosis for hemodialysis including direct feed and indirect feed options, wastewater treatment for dialysis units, and guarantees services for at least one year with 24-hour support; produces and distributes dialysate solutions in acid (Mc-A) and bicarbonate (Mc-B) types compliant with GMP, ISO 13485:2016, and ISO 9001:2015 standards; designs and fits out hemodialysis units; distributes medical equipment and consumables for dialysis; and supplies pneumatic tube systems for medical specimen transport as the representative of Telecom Bedrijfscommunicat B.V. from the Netherlands. The company serves public and private sector dialysis units primarily in Thailand with a focus on chronic kidney disease patients.